Skip to content

Ketamine: all studies

Page 403 of 448: studies 4,021 to 4,030 of 4,475, newest first. Back to the ketamine overview

Research

Substance Use and Attendance Motives of Electronic Dance Music (EDM) Event Attendees: A Survey Study

International Journal of Environmental Research and Public Health January 19, 2023 Koen Ponnet, Bert Hauspie, Nicky Dirkx et al. 21 citations

EDM event attendees are a high-risk population for substance use and associated adverse effects. The aim of this study was to examine substance use at EDM events, focusing on associations between attendance motives and substance use. Sociodemographic characteristics, event specifics, past-year use, and attendance motives were assessed through an online survey. Participants were 1345 Belgian EDM...

DOI: 10.3390/ijerph20031821 (opens in new tab) Ecstasy Cannabis Electronic dance music Attendance +1

Neurometabolite changes in response to antidepressant medication: A systematic review of 1H-MRS findings.

NeuroImage: Clinical 2023 Daphne E Boucherie, Liesbeth Reneman, Henricus G. Ruhé et al.

Selective serotonin reuptake inhibitors (SSRIs), serotonin and noradrenaline reuptake inhibitors (SNRIs), and (es)ketamine are used to treat major depressive disorder (MDD). These different types of medication may involve common neural pathways related to glutamatergic and GABAergic neurotransmitter systems, both of which have been implicated in MDD pathology. We conducted a systematic review...

Clínicas de ketamina: usos actuales según la evidencia

Revista Mexicana de Anestesiología 2023 Selene Sharid Torres-Valdés, Orlando Carrillo-Torres, Dulce María Rascón-Martínez 3 citations

RESUMEN.La ketamina es un medicamento conocido por sus bondades como inductor anestésico y para disminuir la posibilidad de complicaciones, por ejemplo, exacerbación del dolor neuropático e hiperalgesia asociada a opioides.En esta revisión nos enfocaremos en otras indicaciones en las que también ha demostrado ser útil y que, bajo observación e instrucción adecuadas en una infraestructura...

Altered dynamical integration/segregation balance during anesthesia-induced loss of consciousness.

Frontiers in Network Physiology 2023 Louis-David Lord, Timoteo Carletti, Henrique M. Fernandes et al.

In recent years, brain imaging studies have begun to shed light on the neural correlates of physiologically-reversible altered states of consciousness such as deep sleep, anesthesia, and psychedelic experiences. The emerging consensus is that normal waking consciousness requires the exploration of a dynamical repertoire enabling both global integration i.e., long-distance interactions between...

DOI: 10.3389/fnetp.2023.1279646 (opens in new tab) Full text (opens in new tab) Ecog Anesthesia Integration/segregation Neural synchronisation

Uso de sustancias psicoactivas como tratamiento de la psicosis

Revista de Neurología 2023 E Serrano-Jiménez, M G de Lucas-Moreno

INTRODUCTION: Psychotic disorders are considered chronic mental health issues. Although it has been demonstrated that these disorders can present with a wide range of symptoms, pharmacological treatment is based on the use of typical and atypical antipsychotics, whose main mechanism of action is dopaminergic blockade, limiting their effect to the improvement of positive symptoms, without...

DOI: 10.33588/rn.7611.2023077 (opens in new tab) Full text (opens in new tab) Psycinfo Amisulpride Schizophrenia object-oriented programming Tolerability +4

Better Biomarkers, Faster Drugs, Stronger Models: Progress Towards Precision Psychiatry.

Missouri medicine 2023 Joshua S. Siegel, Craig S Pearson, Eric J Lenze 592 citations

The 21st century has brought novel therapies and new therapeutic targets for major depressive disorder (MDD). Until recently all antidepressant medications targeted monoamines-serotonin, norepinephrine, and dopamine- and their regulatory systems. But growing evidence has suggested that individuals who fail to respond to a monoaminergic treatment are likely to fail to respond to other...

Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness

Journal of Psychopharmacology 2023 Matthias Forstmann, Christina Sagioglou, Alexander Irvine et al. 18 citations

Background: Past research reports a positive relationship between experience with classic serotonergic psychedelics and nature relatedness (NR). However, these studies typically do not distinguish between different psychedelic compounds, which have a unique psychopharmacology and may be used in specific contexts and with different intentions. Likewise, it is not clear whether these findings can...

The thalamus in psychosis spectrum disorder.

Frontiers in Neuroscience 2023 Alan Anticevic, Michael M. Halassa 41 citations

Psychosis spectrum disorder (PSD) affects 1% of the world population and results in a lifetime of chronic disability, causing devastating personal and economic consequences. Developing new treatments for PSD remains a challenge, particularly those that target its core cognitive deficits. A key barrier to progress is the tenuous link between the basic neurobiological understanding of PSD and its...

DOI: 10.3389/fnins.2023.1163600 (opens in new tab) Full text (opens in new tab) Cognition Computation Functional connectivity Pharmacology +4

The Resurgence of Hallucinogen Drugs in Clinical Research.

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 2023 María T Rivera-García, Silvia L. Cruz 8 citations

Since the dawn of civilization, ancient cultures have utilized hallucinogens from plants and fungi in the context of religious and healing practices. Recently, their use has expanded to other cultures. Hallucinogens are natural or synthetic substances that alter the perception of reality at nontoxic doses, producing intense psychological and physiological effects. The initial research on...

Use of psychoactive substances by goods carriage drivers associated with Kerala, India.

Traffic injury prevention 2023 M S Siva Prasad, C V Priyatha, Jayesh K Joseph et al.

This study aimed to measure the prevalence of drugs of abuse (DOA) among the goods carriage drivers associated with the southern State of India, Kerala. Point-of-collection testing (POCT) of oral fluid collected from the participants (n = 249) was done using the Evidence MultiSTAT DOA Oral Fluid II Assay kits and the Evidence MultiSTAT analyzer. Out of the total samples, 53 (21.29%) were...

DOI: 10.1080/15389588.2023.2246163 (opens in new tab) Full text (opens in new tab) New psychoactive substances Bio-chip array technology Drivers Point-of-collection testing +4